Factors which interact with oncoproteins
AssigneeLudwig Institute for Cancer Research
InventorsXin Lu, Shan Zhong
Life of this patent
Estimating the term…
Abstract
The invention relates to polypeptides that bind to the oncogene product mdm2 and the uses of the identified polypeptides in therapeutic compositions to treat aberrant cell division in humans.
Claims6
A method for modulating cell division regulation comprising the introduction to a cell in vitro at least one agent for binding with mdm2 in the cell, wherein the agent is a polypeptide encoded by a nucleic acid selected from the group consisting of SEQ ID NO:
- 1, SEQ ID NO:
- 2, SEQ ID NO:
- 3, SEQ ID NO:
- 4, SEQ ID NO:
- 5, SEQ ID NO:
- 6, SEQ ID NO:
- 7, SEQ ID NO:
- 8, SEQ ID NO:
- 9, SEQ ID NO:
- 10, SEQ ID NO:
- 11, SEQ ID NO:
- 12, SEQ ID NO:
- 13, and SEQ ID NO:
- 14, or a fragment of the polypeptide thereof that binds mdm2.
A composition for use in modulating apoptosis through interaction with mdm2 comprising a suitable carrier dilutant or excipient and at least one agent, wherein the agent is a polypeptide encoded by a nucleic acid selected from the group consisting of SEQ ID NO:
- 1, SEQ ID NO:
- 2, SEQ ID NO:
- 4, SEQ ID NO:
- 5, SEQ ID NO:
- 6, SEQ ID NO:
- 7, SEQ ID NO:
- 8, SEQ ID NO:
- 9, SEQ ID NO:
- 10, SEQ ID NO:
- 11, SEQ ID NO:
- 12, SEQ ID NO:
- 13, and SEQ ID NO:
- 14, or a fragment of the polypeptide thereof that binds mdm2.
A method of using a polypeptide encoded by SEQ ID NO:
- 3 in the manufacture of a composition for use in modulating apoptosis through interaction with mdm2, comprising combining the polypeptide with a suitable carrier dilutant or excipient.
A diagnostic/prognostic assay kit for determining cell division regulation comprising a means for determining cellular levels of a polypeptide and/or a means for detecting the polypeptide, wherein the polypeptide is encoded by a nucleic acid selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:
- 9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:
- 12, SEQ ID NO:
- 13, and SEQ ID NO:
- 14, or a fragment of the polypeptide thereof that binds mdm2.
A method for treating aberrant cell division so as to arrest, mitigate or reverse said aberrant cell division wherein said method comprises administering to a cell in vitro to be treated an effective amount of at least one agent, wherein the agent is a polypeptide encoded by a nucleic acid selected from the group consisting of SEQ ID NO:
- 1, SEQ ID NO:
- 2, SEQ ID NO:
- 3, SEQ ID NO:
- 4, SEQ ID NO:
- 5, SEQ ID NO:
- 6, SEQ ID NO:
- 7, SEQ ID NO:
- 8, SEQ ID NO:
- 9, SEQ ID NO:
- 10, SEQ ID NO:
- 11, SEQ ID NO:
- 12, SEQ ID NO:
- 13, and SEQ ID NO:
- 14, or a fragment of the polypeptide thereof that binds mdm2.
Dependencies are inferred from the claim text.